Clinical Trials

ACTHAR® STUDY - Membranous Nephropathy (H-29014)

This study will compare ACTHAR Gel to placebo for treatment of persistent proteinuria and nephrotic syndrome due to idiopathic membranous nephropathy (iMN). Study drug (or placebo) will be given as injections 2 times a week for 6 months with 6 months of follow up.

Site: Harris Health Smith Clinic

Study Doctor: Rajeev Raghavan, M.D.

Study Contact: Patricia Marino (713) 798-4516 or prmarino@bcm.edu

Open and actively recruiting